Elizabeth A Musgrove

Elizabeth A Musgrove

UNVERIFIED PROFILE

Are you Elizabeth A Musgrove?   Register this Author

Register author
Elizabeth A Musgrove

Elizabeth A Musgrove

Publications by authors named "Elizabeth A Musgrove"

Are you Elizabeth A Musgrove?   Register this Author

78Publications

1986Reads

6Profile Views

Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours.

Authors:
Aldo Scarpa David K Chang Katia Nones Vincenzo Corbo Ann-Marie Patch Peter Bailey Rita T Lawlor Amber L Johns David K Miller Andrea Mafficini Borislav Rusev Maria Scardoni Davide Antonello Stefano Barbi Katarzyna O Sikora Sara Cingarlini Caterina Vicentini Skye McKay Michael C J Quinn Timothy J C Bruxner Angelika N Christ Ivon Harliwong Senel Idrisoglu Suzanne McLean Craig Nourse Ehsan Nourbakhsh Peter J Wilson Matthew J Anderson J Lynn Fink Felicity Newell Nick Waddell Oliver Holmes Stephen H Kazakoff Conrad Leonard Scott Wood Qinying Xu Shivashankar Hiriyur Nagaraj Eliana Amato Irene Dalai Samantha Bersani Ivana Cataldo Angelo P Dei Tos Paola Capelli Maria Vittoria Davì Luca Landoni Anna Malpaga Marco Miotto Vicki L J Whitehall Barbara A Leggett Janelle L Harris Jonathan Harris Marc D Jones Jeremy Humphris Lorraine A Chantrill Venessa Chin Adnan M Nagrial Marina Pajic Christopher J Scarlett Andreia Pinho Ilse Rooman Christopher Toon Jianmin Wu Mark Pinese Mark Cowley Andrew Barbour Amanda Mawson Emily S Humphrey Emily K Colvin Angela Chou Jessica A Lovell Nigel B Jamieson Fraser Duthie Marie-Claude Gingras William E Fisher Rebecca A Dagg Loretta M S Lau Michael Lee Hilda A Pickett Roger R Reddel Jaswinder S Samra James G Kench Neil D Merrett Krishna Epari Nam Q Nguyen Nikolajs Zeps Massimo Falconi Michele Simbolo Giovanni Butturini George Van Buren Stefano Partelli Matteo Fassan Kum Kum Khanna Anthony J Gill David A Wheeler Richard A Gibbs Elizabeth A Musgrove Claudio Bassi Giampaolo Tortora Paolo Pederzoli John V Pearson Nicola Waddell Andrew V Biankin Sean M Grimmond

Nature 2017 10 27;550(7677):548. Epub 2017 Sep 27.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature24026DOI Listing
October 2017

Whole-genome landscape of pancreatic neuroendocrine tumours.

Authors:
Aldo Scarpa David K Chang Katia Nones Vincenzo Corbo Ann-Marie Patch Peter Bailey Rita T Lawlor Amber L Johns David K Miller Andrea Mafficini Borislav Rusev Maria Scardoni Davide Antonello Stefano Barbi Katarzyna O Sikora Sara Cingarlini Caterina Vicentini Skye McKay Michael C J Quinn Timothy J C Bruxner Angelika N Christ Ivon Harliwong Senel Idrisoglu Suzanne McLean Craig Nourse Ehsan Nourbakhsh Peter J Wilson Matthew J Anderson J Lynn Fink Felicity Newell Nick Waddell Oliver Holmes Stephen H Kazakoff Conrad Leonard Scott Wood Qinying Xu Shivashankar Hiriyur Nagaraj Eliana Amato Irene Dalai Samantha Bersani Ivana Cataldo Angelo P Dei Tos Paola Capelli Maria Vittoria Davì Luca Landoni Anna Malpaga Marco Miotto Vicki L J Whitehall Barbara A Leggett Janelle L Harris Jonathan Harris Marc D Jones Jeremy Humphris Lorraine A Chantrill Venessa Chin Adnan M Nagrial Marina Pajic Christopher J Scarlett Andreia Pinho Ilse Rooman Christopher Toon Jianmin Wu Mark Pinese Mark Cowley Andrew Barbour Amanda Mawson Emily S Humphrey Emily K Colvin Angela Chou Jessica A Lovell Nigel B Jamieson Fraser Duthie Marie-Claude Gingras William E Fisher Rebecca A Dagg Loretta M S Lau Michael Lee Hilda A Pickett Roger R Reddel Jaswinder S Samra James G Kench Neil D Merrett Krishna Epari Nam Q Nguyen Nikolajs Zeps Massimo Falconi Michele Simbolo Giovanni Butturini George Van Buren Stefano Partelli Matteo Fassan Kum Kum Khanna Anthony J Gill David A Wheeler Richard A Gibbs Elizabeth A Musgrove Claudio Bassi Giampaolo Tortora Paolo Pederzoli John V Pearson Nicola Waddell Andrew V Biankin Sean M Grimmond

Nature 2017 03 15;543(7643):65-71. Epub 2017 Feb 15.

University of Melbourne Centre for Cancer Research, University of Melbourne, Melbourne, 3010, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature21063DOI Listing
March 2017

Hypermutation In Pancreatic Cancer.

Gastroenterology 2017 01 15;152(1):68-74.e2. Epub 2016 Nov 15.

Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom; Department of Surgery, Bankstown Hospital, Bankstown, Sydney, New South Wales, Australia; South Western Sydney Clinical School, Faculty of Medicine, University of New South Wales Australia, Liverpool, New South Wales, Australia; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00165085163518
Publisher Site
http://dx.doi.org/10.1053/j.gastro.2016.09.060DOI Listing
January 2017

Genomic analyses identify molecular subtypes of pancreatic cancer.

Authors:
Peter Bailey David K Chang Katia Nones Amber L Johns Ann-Marie Patch Marie-Claude Gingras David K Miller Angelika N Christ Tim J C Bruxner Michael C Quinn Craig Nourse L Charles Murtaugh Ivon Harliwong Senel Idrisoglu Suzanne Manning Ehsan Nourbakhsh Shivangi Wani Lynn Fink Oliver Holmes Venessa Chin Matthew J Anderson Stephen Kazakoff Conrad Leonard Felicity Newell Nick Waddell Scott Wood Qinying Xu Peter J Wilson Nicole Cloonan Karin S Kassahn Darrin Taylor Kelly Quek Alan Robertson Lorena Pantano Laura Mincarelli Luis N Sanchez Lisa Evers Jianmin Wu Mark Pinese Mark J Cowley Marc D Jones Emily K Colvin Adnan M Nagrial Emily S Humphrey Lorraine A Chantrill Amanda Mawson Jeremy Humphris Angela Chou Marina Pajic Christopher J Scarlett Andreia V Pinho Marc Giry-Laterriere Ilse Rooman Jaswinder S Samra James G Kench Jessica A Lovell Neil D Merrett Christopher W Toon Krishna Epari Nam Q Nguyen Andrew Barbour Nikolajs Zeps Kim Moran-Jones Nigel B Jamieson Janet S Graham Fraser Duthie Karin Oien Jane Hair Robert Grützmann Anirban Maitra Christine A Iacobuzio-Donahue Christopher L Wolfgang Richard A Morgan Rita T Lawlor Vincenzo Corbo Claudio Bassi Borislav Rusev Paola Capelli Roberto Salvia Giampaolo Tortora Debabrata Mukhopadhyay Gloria M Petersen Donna M Munzy William E Fisher Saadia A Karim James R Eshleman Ralph H Hruban Christian Pilarsky Jennifer P Morton Owen J Sansom Aldo Scarpa Elizabeth A Musgrove Ulla-Maja Hagbo Bailey Oliver Hofmann Robert L Sutherland David A Wheeler Anthony J Gill Richard A Gibbs John V Pearson Nicola Waddell Andrew V Biankin Sean M Grimmond

Nature 2016 Mar 24;531(7592):47-52. Epub 2016 Feb 24.

Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, Queensland 4072, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature16965DOI Listing
March 2016

DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer.

Nat Commun 2015 Jul 14;6:7758. Epub 2015 Jul 14.

1] Epigenetics Research Program, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia [2] Faculty of Medicine, St Vincent's Clinical School, UNSW, NSW 2052 &St Vincent's Hospital, Sydney, New South Wales 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms8758DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510968PMC
July 2015

Cyclin E2 is the predominant E-cyclin associated with NPAT in breast cancer cells.

Cell Div 2015 19;10. Epub 2015 Feb 19.

The Kinghorn Cancer Centre and Cancer Research Program, Garvan Institute of Medical Research, Sydney, NSW Australia ; St Vincent's Clinical School, Faculty of Medicine UNSW, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13008-015-0007-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349318PMC
March 2015

Whole genomes redefine the mutational landscape of pancreatic cancer.

Nature 2015 Feb;518(7540):495-501

1] Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, Queensland 4072, Australia [2] Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature14169DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523082PMC
February 2015

Clinical and pathologic features of familial pancreatic cancer.

Cancer 2014 Dec 14;120(23):3669-75. Epub 2014 Oct 14.

The Kinghorn Cancer Center, Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28863DOI Listing
December 2014

Clinical and molecular characterization of HER2 amplified-pancreatic cancer.

Genome Med 2013 31;5(8):78. Epub 2013 Aug 31.

Kinghorn Cancer Centre and Garvan Institute of Medical Research, Darlinghurst, Sydney, Australia ; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK ; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/gm482DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978667PMC
May 2014

Endocrine therapy: defining the path of least resistance.

Breast Cancer Res 2014 May 22;16(3):101. Epub 2014 May 22.

Wolfson Wohl Cancer Research Centre, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, Bearsden, G61 1QH, Scotland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr3659DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053240PMC
May 2014

Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells.

BMC Cancer 2014 Jan 20;14:32. Epub 2014 Jan 20.

The Kinghorn Cancer Centre and Cancer Research Division, Garvan Institute of Medical Research, 370 Victoria Street, Darlinghurst, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-14-32DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903446PMC
January 2014

Sulindac activates NF-κB signaling in colon cancer cells.

Cell Commun Signal 2013 Oct 1;11:73. Epub 2013 Oct 1.

Kinghorn Cancer Centre, Garvan Institute of Medical Research, 370 Victoria St, Darlinghurst, Sydney, NSW 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1478-811X-11-73DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896984PMC
October 2013

BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer.

Mol Cancer Ther 2013 Sep 16;12(9):1874-85. Epub 2013 Jul 16.

Corresponding Author: Andrew Stone, Garvan Institute of Medical Research, L9 TKCC, 370 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-13-0012DOI Listing
September 2013

Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells.

Cell Cycle 2013 Feb 16;12(4):596-605. Epub 2013 Jan 16.

The Kinghorn Cancer Centre and Cancer Research Program, Garvan Institute of Medical Research, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.23409DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594260PMC
February 2013

Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1.

Cell Cycle 2013 Feb 16;12(4):606-17. Epub 2013 Jan 16.

The Kinghorn Cancer Centre and Cancer Research Program, Garvan Institute of Medical Research, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.23512DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594261PMC
February 2013

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.

Authors:
Andrew V Biankin Nicola Waddell Karin S Kassahn Marie-Claude Gingras Lakshmi B Muthuswamy Amber L Johns David K Miller Peter J Wilson Ann-Marie Patch Jianmin Wu David K Chang Mark J Cowley Brooke B Gardiner Sarah Song Ivon Harliwong Senel Idrisoglu Craig Nourse Ehsan Nourbakhsh Suzanne Manning Shivangi Wani Milena Gongora Marina Pajic Christopher J Scarlett Anthony J Gill Andreia V Pinho Ilse Rooman Matthew Anderson Oliver Holmes Conrad Leonard Darrin Taylor Scott Wood Qinying Xu Katia Nones J Lynn Fink Angelika Christ Tim Bruxner Nicole Cloonan Gabriel Kolle Felicity Newell Mark Pinese R Scott Mead Jeremy L Humphris Warren Kaplan Marc D Jones Emily K Colvin Adnan M Nagrial Emily S Humphrey Angela Chou Venessa T Chin Lorraine A Chantrill Amanda Mawson Jaswinder S Samra James G Kench Jessica A Lovell Roger J Daly Neil D Merrett Christopher Toon Krishna Epari Nam Q Nguyen Andrew Barbour Nikolajs Zeps Nipun Kakkar Fengmei Zhao Yuan Qing Wu Min Wang Donna M Muzny William E Fisher F Charles Brunicardi Sally E Hodges Jeffrey G Reid Jennifer Drummond Kyle Chang Yi Han Lora R Lewis Huyen Dinh Christian J Buhay Timothy Beck Lee Timms Michelle Sam Kimberly Begley Andrew Brown Deepa Pai Ami Panchal Nicholas Buchner Richard De Borja Robert E Denroche Christina K Yung Stefano Serra Nicole Onetto Debabrata Mukhopadhyay Ming-Sound Tsao Patricia A Shaw Gloria M Petersen Steven Gallinger Ralph H Hruban Anirban Maitra Christine A Iacobuzio-Donahue Richard D Schulick Christopher L Wolfgang Richard A Morgan Rita T Lawlor Paola Capelli Vincenzo Corbo Maria Scardoni Giampaolo Tortora Margaret A Tempero Karen M Mann Nancy A Jenkins Pedro A Perez-Mancera David J Adams David A Largaespada Lodewyk F A Wessels Alistair G Rust Lincoln D Stein David A Tuveson Neal G Copeland Elizabeth A Musgrove Aldo Scarpa James R Eshleman Thomas J Hudson Robert L Sutherland David A Wheeler John V Pearson John D McPherson Richard A Gibbs Sean M Grimmond

Nature 2012 Nov 24;491(7424):399-405. Epub 2012 Oct 24.

The Kinghorn Cancer Centre, 370 Victoria Street, Darlinghurst, Sydney, New South Wales 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature11547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530898PMC
November 2012

The PDZ-binding motif of MCC is phosphorylated at position -1 and controls lamellipodia formation in colon epithelial cells.

Biochim Biophys Acta 2012 Jun 28;1823(6):1058-67. Epub 2012 Mar 28.

Cancer Research Program, Garvan Institute of Medical Research, Sydney, Australia.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01674889120007
Publisher Site
http://dx.doi.org/10.1016/j.bbamcr.2012.03.011DOI Listing
June 2012

Inhibitors of cell cycle kinases: recent advances and future prospects as cancer therapeutics.

Crit Rev Oncog 2012 ;17(2):175-98

Garvan Institute of Medical Research, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
May 2012

Mutated in colorectal cancer protein modulates the NFκB pathway.

Anticancer Res 2012 Jan;32(1):73-9

Cancer Research Program, Garvan Institute of Medical Research, 384 Victoria Street, Sydney NSW 2010, Australia.

View Article

Download full-text PDF

Source
January 2012

Estrogen receptor degradation: a CUE for endocrine resistance?

Breast Cancer Res 2011 Aug 16;13(4):312. Epub 2011 Aug 16.

Cancer Research Program, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr2914DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236333PMC
August 2011

Cyclin D as a therapeutic target in cancer.

Nat Rev Cancer 2011 Jul 7;11(8):558-72. Epub 2011 Jul 7.

Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, Sydney NSW 2010, Australia.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrc3090
Publisher Site
http://dx.doi.org/10.1038/nrc3090DOI Listing
July 2011

The NSAID sulindac is chemopreventive in the mouse distal colon but carcinogenic in the proximal colon.

Gut 2011 Mar 27;60(3):350-60. Epub 2010 Oct 27.

Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst Sydney NSW 2010, Australia.

View Article

Download full-text PDF

Source
http://gut.bmj.com/cgi/doi/10.1136/gut.2010.208314
Publisher Site
http://dx.doi.org/10.1136/gut.2010.208314DOI Listing
March 2011

PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality.

Int J Cancer 2010 Mar;126(5):1121-31

Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, Sydney, NSW 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.24831DOI Listing
March 2010

Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients.

Cancer Epidemiol Biomarkers Prev 2010 Jan;19(1):301-9

Cancer Research Program, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-09-0741DOI Listing
January 2010

Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer.

Cell Div 2010 Jan 17;5. Epub 2010 Jan 17.

Cancer Research Program, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.

View Article

Download full-text PDF

Source
http://celldiv.biomedcentral.com/articles/10.1186/1747-1028-
Publisher Site
http://dx.doi.org/10.1186/1747-1028-5-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835679PMC
January 2010

Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc.

Mol Cell Biol 2009 Sep 29;29(17):4623-39. Epub 2009 Jun 29.

Cancer Research Program, Garvan Institute of Medical Research, NSW, Australia.

View Article

Download full-text PDF

Source
http://mcb.asm.org/cgi/doi/10.1128/MCB.00269-09
Publisher Site
http://dx.doi.org/10.1128/MCB.00269-09DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725719PMC
September 2009

Biological determinants of endocrine resistance in breast cancer.

Nat Rev Cancer 2009 Sep;9(9):631-43

Cancer Research Program, Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc2713DOI Listing
September 2009

Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer.

Histol Histopathol 2009 03;24(3):385-98

Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14670/HH-24.385DOI Listing
March 2009

Cell cycle machinery: links with genesis and treatment of breast cancer.

Adv Exp Med Biol 2008 ;630:189-205

Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-0-387-78818-0_12DOI Listing
August 2008

The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome.

Breast Cancer Res 2008 29;10(2):R28. Epub 2008 Mar 29.

Cancer Research Program, Garvan Institute of Medical Research, St, Vincent's Hospital, Victoria Street, Darlinghurst, New South Wales 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr1985DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2397527PMC
July 2008

The helix-loop-helix protein Id1 requires cyclin D1 to promote the proliferation of mammary epithelial cell acini.

Cancer Res 2008 Apr;68(8):3026-36

Cancer Research Program, Garvan Institute of Medical Research, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/content/68/8/3026.full.pdf
Web Search
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-07-3079DOI Listing
April 2008

Live or let die: oestrogen regulation of survival signalling in endocrine response.

Breast Cancer Res 2007 ;9(5):306

Cancer Research Program, Garvan Institute of Medical Research, St, Vincent's Hospital, Darlinghurst, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr1779DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2242668PMC
March 2008

The E3 ubiquitin ligase EDD regulates S-phase and G(2)/M DNA damage checkpoints.

Cell Cycle 2007 Dec 7;6(24):3070-7. Epub 2007 Sep 7.

Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.6.24.5021DOI Listing
December 2007

c-Myc overexpression and endocrine resistance in breast cancer.

J Steroid Biochem Mol Biol 2006 Dec 18;102(1-5):147-55. Epub 2006 Oct 18.

Cancer Research Program, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, NSW 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jsbmb.2006.09.028DOI Listing
December 2006

Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.

Cancer Epidemiol Biomarkers Prev 2006 Oct;15(10):1941-7

Cancer Research Program, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, Sydney, New South Wales 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-06-0319DOI Listing
October 2006

Cyclins: roles in mitogenic signaling and oncogenic transformation.

Growth Factors 2006 Mar;24(1):13-9

Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/08977190500361812DOI Listing
March 2006

Cell cycle control in breast cancer cells.

J Cell Biochem 2006 Feb;97(2):261-74

Cancer Research Program, Garvan Institute of Medical Research, St Vincent's Hospital, Sydney, NSW 2010, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jcb.20690
Publisher Site
http://dx.doi.org/10.1002/jcb.20690DOI Listing
February 2006

Increased proliferation and altered growth factor dependence of human mammary epithelial cells overexpressing the Gab2 docking protein.

J Biol Chem 2006 Jan 27;281(1):626-37. Epub 2005 Oct 27.

Cancer Research Program, Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M509567200DOI Listing
January 2006

Wnt signalling via the epidermal growth factor receptor: a role in breast cancer?

Breast Cancer Res 2004 24;6(2):65-8. Epub 2003 Oct 24.

Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr737DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC400647PMC
July 2005

Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E.

Endocr Relat Cancer 2005 Jul;12 Suppl 1:S47-59

Cancer Research Program, Garvan Institute of Medical Research, St Vincent's Hospital, Darlinghurst, New South Wales 2010, Australia.

View Article

Download full-text PDF

Source
https://erc.bioscientifica.com/view/journals/erc/12/Suppleme
Publisher Site
http://dx.doi.org/10.1677/erc.1.00993DOI Listing
July 2005

p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue.

Clin Cancer Res 2005 Jun;11(11):4107-16

Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-04-2036DOI Listing
June 2005

Hormonal regulation of the Grb14 signal modulator and its role in cell cycle progression of MCF-7 human breast cancer cells.

J Cell Physiol 2005 Apr;203(1):85-93

Cancer Research Program, Garvan Institute of Medical Research, St Vincent's Hospital, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.20199DOI Listing
April 2005

Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1.

Oncogene 2005 Jan;24(3):381-9

Cancer Research Program, Garvan Institute of Medical Research, St Vincent's Hospital, 384 Victoria St, Darlinghurst, Sydney, NSW 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1208188DOI Listing
January 2005

Role of the CDK inhibitor p27 (Kip1) in mammary development and carcinogenesis: insights from knockout mice.

J Mammary Gland Biol Neoplasia 2004 Jan;9(1):55-66

Cancer Research Program, Garvan Institute of Medical Research, St Vincent's Hospital, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/B:JOMG.0000023588.55733.84DOI Listing
January 2004

Cyclins and breast cancer.

J Mammary Gland Biol Neoplasia 2004 Jan;9(1):95-104

Cancer Research Program, Garvan Institute of Medical Research, St Vincent's Hospital, Darlinghurst, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/B:JOMG.0000023591.45568.77DOI Listing
January 2004

Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue.

Clin Cancer Res 2003 Sep;9(10 Pt 1):3705-11

Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia.

View Article

Download full-text PDF

Source
September 2003

p27(Kip1) induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells.

Cancer Res 2003 Aug;63(15):4322-6

Cancer Research Program, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, New South Wales 2010, Australia.

View Article

Download full-text PDF

Source
August 2003

Cyclin D1, EMS1 and 11q13 amplification in breast cancer.

Breast Cancer Res Treat 2003 Apr;78(3):323-35

Cancer Research Program, Garvan Institute of Medical Research, St. Vincent's Hospital, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/a:1023033708204DOI Listing
April 2003

Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models.

Breast Cancer Res 2002 30;4(1):14-7. Epub 2001 Nov 30.

Cancer Research Program, Garvan Institute of Medical Research, St Vincent's Hospital, Sydney, Australia.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC154565PMC
December 2002

Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells.

Cancer Res 2002 Dec;62(23):6916-23

Cancer Research Program, Garvan Institute of Medical Research, St. Vincent's Hospital, Darlinghurst, Sydney, New South Wales 2010, Australia.

View Article

Download full-text PDF

Source
December 2002

Cyclin E and prognosis in patients with breast cancer.

N Engl J Med 2002 Nov;347(20):1546-7

Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/abs/10.1056/NEJMNEJMp020124
Publisher Site
http://dx.doi.org/10.1056/NEJMNEJMp020124DOI Listing
November 2002

Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.

Cancer Res 2002 Jun;62(11):3126-31

Cancer Research Program, Garvan Institute of Medical Research, St. Vincent's Hospital, 384 Victoria Street, Darlinghurst, Sydney, New South Wales 2010, Australia.

View Article

Download full-text PDF

Source
June 2002